2023

1. In vitro activity of ceftobiprole and dalbavancin against a collection of coagulase-negative staphylococci isolates from clinical samples with reduced susceptibility to daptomycin and/or resistant to linezolid or glycopeptides

   Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 9, pp. 567-570